Latest / Community Health Media
Navigating CLL From Frontline to Relapse with Drs. Joanna Rhodes, Prioty Islam & Nicole Lamanna
What shapes treatment decisions in chronic lymphocytic leukemia (CLL), from frontline therapy through relapse?
Dr. Joanna Rhodes, Dr. Prioty Islam, and Dr. Nicole Lamanna discuss the evolving CLL treatment landscape and share how they approach continuous and fixed-duration therapy, high-risk disease, and toxicity management in everyday practice.
They explore how genomic testing, patient preferences, and emerging clinical evidence guide their choices, including the growing role of combination regimens.
Topics discussed:
Continuous and fixed-duration frontline CLL therapy
TP53, del(17p), and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.